Research Article

Distribution of Microbes and Drug Susceptibility in Patients with Diabetic Foot Infections in Southwest China

Table 4

The susceptible pattern of gram-negative bacteria from diabetic foot patients.

E. coliSerratiaKlebsiellaEnterobacterProteusbacillusPseudomonasbaumanniiMorganella

Macrodantin (%)79.31035.155.62.614.30
Ampicillin (%)21.95.4055.6000
Ampicillin/sulbactam (%)25.848.6073.75.9500
Piperacillin-tazobactam (%)87.910094.684.210074.48096
Sulfamethoxazole (%)31.394.767.661.952.65.364.340
Cefazolin (%)22.25.32718.8003.8
Cefoxitin (%)100
Ceftriaxone (%)32.310070.371.40076.9
Ceftazidime (%)62.510089.28110087.266.788.5
Cefotetan (%)9094.69.100100
Cefepime (%)66.794.794.690.573.789.771.490.5
Levofloxacin (%)39.494.783.87573.789.573.392.3
Ciprofloxacin (%)30.394.781.17057.987.273.365.4
Amikacin (%)46.978.975.776.263.287.293.353.8
Tobramycin (%)9710094.693.388.989.588.5
Gentamicin (%)46.994.778.495.268.484.693.353.8
Meropenem (%)10094.3100
Imipenem (%)93.589.510010068.482.173.3
Ertapenem (%)96.410010094.7100100
Aztreonam (%)48.584.283.876.284.222.2100